Volume 11 Supplement 1

5th International Conference on cGMP: Generators, Effectors and Therapeutic Implications

Open Access

NO-donors induce cross talk between cGMP and cAMP in signalling to human atrial L-type Ca2+ current

  • Nadiia Rozmaritsa1Email author,
  • Torsten Christ1,
  • Erich Wettwer1 and
  • Ursula Ravens1
BMC Pharmacology201111(Suppl 1):P55

https://doi.org/10.1186/1471-2210-11-S1-P55

Published: 1 August 2011

Background

Cardiac NO-activated pathways are discussed to involve cross-talk between cGMP and cAMP signalling [1, 2]. Here we have investigated the signalling pathways relating to NO-donor S-nitroso-N-acetylpenicillamine (SNAP) modulation of L-type Ca2+ current (ICa,L) in human right atrial cardiomyocytes.

Material and methods

Experiments were performed on human biopsy tissue from 62 patients in sinus rhythm. ICa,L was measured with whole-cell voltage-clamp technique.

Results

Application of SNAP (100µM) increased basal ICa,L from 5.93±0.23 pA/pF to 9.10±0.45pA/pF (p<0.001, n/N=117/62). The effect was abolished by inhibition of soluble guanylate cyclase (sGC) with ODQ (30µM), suggesting involvement of cGMP. Stimulator of sGC (BAY 41-2272, 10nM–10µM) also increased ICa,L and this effect was potentiated in the presence of SNAP. Direct activation of protein kinase G (PKG) with 8-Br-cGMP (100 µM, intracellular application) increased basal ICa,L. However, not only cGMP but also cAMP was involved, because, the effect of SNAP on ICa,L was prevented with the protein kinase A blocker (Rp-8-Br-cAMP 1 mM, intracellular). Thus, cGMP may activate ICa,L via direct activation of PKG and indirect activation of PKA at the same time. It is known, that cAMP-mediated activation of PKA is regulated by cGMP via modulation of phosphodiesterases (PDEs). The selective PDE2 inhibitor EHNA (10µM) did not affect basal or SNAP-stimulated ICa,L, therefore PDE2 does not regulate basal cAMP level. In contrast, PDE3 inhibition with cilostamide (1µM) increased basal ICa,L, suggesting that PDE3 is involved in basal cAMP level regulation. Interestingly, the cilostamide-induced increase in ICa,L is blunted upon addition of SNAP, most probably via activation of PDE2 by SNAP-mediated cGMP increase (Figure 1). Similarly, SNAP blunted enhancement of ICa,L by PKA activation with isoprenalin (1µM; 18.07 ± 1.12 pA/pF vs 23.06 ± 1.36 pA/pF, p<0.001, n/N=21-39/18), however, this effect was prevented by PDE2 inhibition with EHNA.
Figure 1

Effect of SNAP (100µM), PDE2 inhibitor (EHNA, 10µM) and PDE3 inhibitor (Cilostamide, 1µM) on ICa,L. SNAP effect in the presence of cilostamide.

Conclusion

We conclude that in human atrial cardiomyocytes NO-donors stimulate production of cGMP with further cross-talk to cAMP via PDE2 and PDE3.

Authors’ Affiliations

(1)
Department of Pharmacology and Toxicology, Dresden University of Technology

References

  1. Castro LR, Schittl J, Fischmeister R: Feedback control through cGMP- dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes. Circ Res. 2010, 107: 1232-1402. 10.1161/CIRCRESAHA.110.226712.View ArticlePubMedGoogle Scholar
  2. Stangherlin A, Gesellchen F, Zoccarato A, Terrin A, Fields LA, Berrera M, Surdo NC, Craig MA, Smith G, Hamilton G, Zaccolo M: cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine- dependent signaling in cardiac myocytes. Circ Res. 2011, 108: 929-939. 10.1161/CIRCRESAHA.110.230698.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Rozmaritsa et al; licensee BioMed Central Ltd. 2011

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement